1. Home
  2. RVLV vs JSPRW Comparison

RVLV vs JSPRW Comparison

Compare RVLV & JSPRW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RVLV
  • JSPRW
  • Stock Information
  • Founded
  • RVLV 2003
  • JSPRW N/A
  • Country
  • RVLV United States
  • JSPRW United States
  • Employees
  • RVLV N/A
  • JSPRW 45
  • Industry
  • RVLV Catalog/Specialty Distribution
  • JSPRW Biotechnology: Pharmaceutical Preparations
  • Sector
  • RVLV Consumer Discretionary
  • JSPRW Health Care
  • Exchange
  • RVLV Nasdaq
  • JSPRW Nasdaq
  • Market Cap
  • RVLV N/A
  • JSPRW N/A
  • IPO Year
  • RVLV 2019
  • JSPRW 2020
  • Fundamental
  • Price
  • RVLV $33.56
  • JSPRW $0.23
  • Analyst Decision
  • RVLV Buy
  • JSPRW
  • Analyst Count
  • RVLV 16
  • JSPRW 0
  • Target Price
  • RVLV $26.03
  • JSPRW N/A
  • AVG Volume (30 Days)
  • RVLV 901.2K
  • JSPRW N/A
  • Earning Date
  • RVLV 11-05-2024
  • JSPRW N/A
  • Dividend Yield
  • RVLV N/A
  • JSPRW N/A
  • EPS Growth
  • RVLV 29.44
  • JSPRW N/A
  • EPS
  • RVLV 0.57
  • JSPRW N/A
  • Revenue
  • RVLV $1,093,961,000.00
  • JSPRW N/A
  • Revenue This Year
  • RVLV $6.58
  • JSPRW N/A
  • Revenue Next Year
  • RVLV $8.52
  • JSPRW N/A
  • P/E Ratio
  • RVLV $58.79
  • JSPRW N/A
  • Revenue Growth
  • RVLV 2.23
  • JSPRW N/A
  • 52 Week Low
  • RVLV $12.63
  • JSPRW N/A
  • 52 Week High
  • RVLV $33.90
  • JSPRW N/A
  • Technical
  • Relative Strength Index (RSI)
  • RVLV 74.91
  • JSPRW N/A
  • Support Level
  • RVLV $30.88
  • JSPRW N/A
  • Resistance Level
  • RVLV $33.82
  • JSPRW N/A
  • Average True Range (ATR)
  • RVLV 1.52
  • JSPRW 0.00
  • MACD
  • RVLV 0.84
  • JSPRW 0.00
  • Stochastic Oscillator
  • RVLV 96.53
  • JSPRW 0.00

About JSPRW Japer Therapeutics Inc.

Jasper Therapeutics Inc is a clinical-stage biotechnology company dedicated to enabling cures through hematopoietic stem cell therapy. It is focused on the development and commercialization of safer and more effective conditioning agents and stem cell engineering to allow for expanded use of stem cell transplantation and ex vivo gene therapy.

Share on Social Networks: